key: cord-0896334-zwqycuw4
authors: Abobaker, Anis; Raba, Ali Ahmed; Alzwi, Aboubaker
title: Extrapulmonary and atypical clinical presentations of COVID‐19
date: 2020-06-10
journal: J Med Virol
DOI: 10.1002/jmv.26157
sha: a49d1aaae0d8ff3fbf0dbeef9b21bf3de30ada7a
doc_id: 896334
cord_uid: zwqycuw4

The novel coronavirus (SARS‐CoV2) has led to outbreak of multiple cases of pneumonia in Wuhan city in December 2019. The disease caused by this virus was named coronavirus disease 2019 or “COVID‐19”, which was declared by WHO as a global pandemic in March 2020. It typically presents with respiratory symptoms and febrile illness. However, there are few reported extrapulmonary and atypical presentations, such as haemoptysis, cardiac, neurological, gastrointestinal, ocular and cutaneous manifestations, as well as venous and arterial thrombosis. Lack of awareness of these presentations might lead to misdiagnosis, delayed diagnosis and isolation of suspected patients which increases the risk of transmission of infection between patients and doctors. All these issues will be discussed in this review. This article is protected by copyright. All rights reserved.

On the 7 th January 2020, a novel coronavirus (SARS-CoV-2) was confirmed as the cause of several cases with pneumonia, which emerged at the end of 2019 in Wuhan, China (1). It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other countries throughout the world. It was declared a global pandemic by the World Health Organisation (WHO) on the 11th March 2020 (2) .

The clinical features of coronavirus infection vary widely, from asymptomatic infection to severe pneumonia with respiratory failure and even death (3, 4) . Approximately 80% of people infected with coronavirus develop mild to moderate disease, 13-14% have severe disease and about 4-6% develop critical disease requiring admission to intensive care unit (ICU) (5) . It has been noted that elderly patients with underlying conditions such as hypertension, diabetes and cardiovascular disease, are more vulnerable to severe disease and death (6) .

Most patients with confirmed COVID-19 present typically with fever, dry cough, sore throat, dyspnoea, fatigue and myalgia (4) . Less common presentations of coronavirus infection include headache, dizziness, nausea, abdominal pain, vomiting and diarrhoea (3, 4) . However, it has been reported that patients with confirmed COVID-19 might present with non-specific or atypical symptoms, which may delay testing, diagnosis and isolation (7) . The exact pathophysiology behind these atypical symptoms is still poorly understood, but advanced age and increase the number of comorbidities might increase the probability of atypical presentations (8, 9) . Few studies proposed that cerebrovascular and neurological symptoms could be explained by hypercoagulability status in patients with COVID-19, leading thrombi formation in the vessels (10) . Another explanation might be related to the fact that SARS-CoV-2 can bind angiotensin converting enzymes 2 (ACE2) receptors, which present in the nervous and reproductive systems (11, 12) .

It is important that healthcare professionals to be aware of the possibility of COVID-19 presenting with non-specific symptoms. Therefore, cases of COVID-19 with extrapulmonary and atypical presentations are not missed when they present to healthcare settings, where healthcare workers should remain vigilant, ensuring appropriate personal protective equipment (PPE) is used. Thus, recognising these presentations is crucial to ensure early diagnosis of these patients and reduce the risk of infection Accepted Article transmission. The objective of this review is to summarise the most important and interesting extrapulmonary and atypical clinical presentations of adults and paediatric patients with COVID-19 that reported in the literature.

Patients with COVID-19 typically presents with respiratory symptoms, such as dry cough and sore throat, associated with general constitutional symptoms, such as headache, fever and myalgia (13). In addition, the Centres for disease control and prevention considered nausea or vomiting, diarrhoea and new loss of taste and smell as recognised features of COVID-19 (14) . However, patients with COVID-19 might develop unusual or atypical manifestations (which means different clinical features or extrapulmonary manifestations not associated with the above typical symptoms that might not be recognised by doctors as related to . They can occur at the onset of the disease or shortly following hospital admission. In the following sections we will give examples for the most important and interesting extrapulmonary and atypical manifestations of COVID-19.

Haemoptysis has been rarely reported as a clinical feature of COVID-19. A prospective analytical study of 41 patients admitted to hospital with confirmed COVID-19 by real-time PCR (RT-PCR) showed that only 5% of patients had haemoptysis at the onset of illness (3) . In another analytical study on a larger study sample (1099 patients with confirmed COVID-19), haemoptysis was only reported in less than 1% of the patients (13). Interestingly, a case report showed that haemoptysis was the only clinical symptom during the first 10 days since the onset of the illness (15). A 57-year-old male with no travel history or history of contact with confirmed COVID-19 cases presented to the emergency department with a 3-hour history of haemoptysis. He had no other symptoms and no previous history of respiratory diseases. The initial computed tomography (CT) scan showed localised ground-glass opacity (GGO) which further progressed to consolidation on day 8 post-admission. A presumptive diagnosis of pulmonary infection/TB was made, but the clinical condition of the patient did not improve despite treatment. On day 11 and 14 post-admission, the patient developed fever and dyspnoea respectively. A repeat CT scan on day 18 post-admission showed partial resolution of the initial findings of GGO and consolidation. However, the rest of the lung field showed diffuse GGO with Accepted Article peripheral and sub-pleural distribution in addition to crazy paving appearance. At that time the possibility of COVID-19 has been considered and the diagnosis was confirmed by RT-PCR (15). The main learning outcome from this case is; lack of awareness of haemoptysis as a possible clinical presentation of COVID-19 has led to initial misdiagnosis and delayed diagnosis. Therefore, COVID-19 should be considered on the differential diagnoses list when dealing with any patient presenting to the hospital with history of haemoptysis even if the other classical clinical features of COVID-19, such as fever, dry cough, myalgia and shortness of breath, are absent.

There are multiple evidences revealed that COVID-19 infection leads to hypercoagulable state.

Laboratory results for patients with confirmed COVID-19 showed an increased level of prothrombotic factors, such as fibrinogen and antiphospholipid antibodies, in addition to high D-dimer levels (16, 17) .

The level of D-dimer was higher in severe disease compared with mild disease which could indicate that D-dimer has a prognostic value (16) . Therefore, patients with COVID-19 are at higher risk to develop venous thrombo-embolic (VTE) events. A 42-year old man diagnosed with mild COVID-19

and was managed effectively at home (18) . However, 12 days later, he presented to the emergency department with a history of worsening central pleuritic chest pain, dyspnoea and haemoptysis. There was no significant past medical history and no history of VTE risk factors. On examination, he was on respiratory distress, there was mild tachypnoea with normal oxygen saturation level. D-dimer level was markedly elevated. Chest X ray showed infiltration in the right lower lobe, and the electrocardiogram (ECG) showed an evidence of right ventricular strain. Giving the previous clinical findings, a CT pulmonary angiogram (CTPA) was ordered. It showed bilateral segmental pulmonary emboli (PE), right lower lobe infarction and GGO with peripheral distribution which is classical for COVID-19 pneumonia (18) . Therefore, it is important for doctors, particularly emergency medicine physicians, to appreciate the potential association between COVID-19 and increased risk of VTE events, such as PE, even in patients without previous VTE risk factors.

Inflammation of the cardiac wall leading to myocarditis, pericarditis and pericardial effusion, are wellrecognised complications of viral infections, such as influnza and parvo B19 infections (19) . This

raises the question of whether COVID-19 disease, considering it is a viral infection, causes similar cardiac complications. A case report described a patient was diagnosed with acute myopericarditis secondary to COVID-19 (20) . The case represented a 53-year old female with one-week history of flulike illness; fever, dry cough and fatigue prior to hospital admission. No history of chest pain, dyspnoea or any other symptoms, and no significant past medical history of cardiac disease. On assessment, she was afebrile but hypotensive. The laboratory results showed high level of troponin T and N-terminal pro-brain natriuretic peptide (NT-proBNP). Chest X ray was normal and the ECG showed diffuse ST Two more patients received a clinical diagnosis of MI based on the findings of focal ST segment elevation with or without regional wall abnormalities on echocardiogram. Interestingly, D-dimer level was more than 2 times higher in the 8 patients diagnosed with MI compared with the 10 patients who had non-coronary myocardial injury. This further emphasises the importance of D-dimer as a prognostic value in COVID-19. Sadly, 13 out of 18 patients died in hospital (21) . This case series demonstrated that COVID-19 does not only cause non-coronary myocardial inflammation and injury, like other viruses, but also leads to thrombotic obstructive coronary artery disease leading to MI.

There are few neurological manifestations of COVID-19 reported in the literature. These are; Guillain-Barre syndrome, viral encephalitis, toxic encephalopathy, acute haemorrhagic necrotizing encephalopathy, olfactory and taste disorders, stroke and non-specific neurological symptoms, such as was confirmed by positive RT-PCR (26) . As this is not the classical sequence of symptoms whereby the viral illness prodrome precedes the neurological symptoms, it is difficult to conclude if this was an association or co-incidence. However, the presence of lymphocytopenia and thrombocytopenia which are classical for COVID-19 might suggest that the patient contracted the infection during her recent stay in Wuhan and she had initial asymptomatic phase of the disease.

Patients with COVID-19 may present with deterioration in conscious level and headache which occur at the time of hospital admission or during hospital stay. This could be either due to central nervous system (CNS) infection or toxic encephalopathy. There are few reported cases of viral encephalitis secondary to COVID-19. The first case presented with history of deterioration of conscious level and Accepted Article confusion two weeks after having classical symptoms of COVID-19 (27) . Although the CSF analysis showed evidence of CNS infection, the RT-PCR failed to detect SARS-CoV-2 genetic materials in the CSF (27) . There was another case of COVID-19 viral encephalitis reported in Beijing Ditan Hospital in which RT-PCR analysis detected SARS-cov2 genome in the CSF (22) . This could indicate that SARS-CoV-2 virus can cross the blood-brain-barrier.

COVID-19 patients can present initially with features of altered conscious level due to toxic encephalopathy (28) . A 74-year-old male with multiple co-morbidities presented to emergency department with a history of fever and cough followed by headache and altered mental status 24-hour later. The patient was diagnosed with encephalopathy as CSF analysis did not show evidence of CNS infection (28) . Interestingly, a rare form of encephalopathy called acute haemorrhagic necrotizing encephalopathy has been reported (29) . A female patient presented with history of fever, cough and altered mental status for 3 days. The diagnosis of COVID-19 has been confirmed by positive RT-PCR result. Brain imaging showed haemorrhagic lesions in bilateral medial thalami and medial temporal lobes, with no evidence of CNS infection on CSF analysis (29) . In summary, during this pandemic, in any patient present to emergency department with altered conscious level and/or confusion the possibility of encephalopathy or viral encephalitis secondary to SARS-CoV-2 infection should be considered.

There are multiple evidences in the literature showed that COVID-19 disease increases the risk of both venous and arterial thrombosis. A case series study showed that 3 critically ill patients with confirmed COVID-19 developed multiple cerebral infarctions, confirmed by brain CT scan, 10 to 33 days after the onset of the initial symptoms of COVID-19 (30) . In another case series study, five out of 78 patients who had confirmed COVID-19 in association with neurological symptoms had acute cerebrovascular disease (4 had ischemic stroke and one had brain haemorrhage) (31) . The incidence of acute neurological complications, such as stroke, seems to be more common in patients having severe COVID-19 compared with patients having mild disease (31) . It is noticed that the incidence of arterial thrombotic events increases steadily in the first 14-day following intensive care unit (ICU) admission (32) . This observation confirms the importance of treating all confirmed COVID-19 patients admitted to ICU with thrombo-prophylactic medications (32) .

Both olfactory and taste dysfunction have been reported as presenting symptoms of COVID-19. They might precede or occur in association with other classical symptoms of COVID-19 or occur in isolation. A survey conducted on 59 COVID-19 patients showed that almost 34% had olfactory and/or taste dysfunction (33) . Another survey conducted on a larger sample; 417 patients with mild to moderate COVID-19, showed that more than 85% had taste and /or smell sensation impairment (34) .

12% had olfactory dysfunction which preceded the onset of other classical symptoms of COVID-19 (34) . A study showed that 17% of COVID-19 patients had only anosmia as an isolated symptom (35) .

Therefore, anosmia can be used as a screening tool to identify asymptomatic carriers and test them.

Self-isolation of asymptomatic carriers who tested positive for COVID-19 could massively reduce the risk of transmission of the infection. In conclusion, during this pandemic time, any patients presented with new onset anosmia or taste dysfunction, the possibly of COVID-19 should be considered

There are few non-specific neurological symptoms reported in patients with COVID-19 with varying frequency. These are dizziness (16.8%), headache (13.1%), muscle injury leading to myalgia and increased serum creatine kinase (10.7%), neuralgia (2.3%), epilepsy (0.5%) and ataxia (0.5%) (23).

There are few reported gastrointestinal symptoms in patients with COVID-19. These are anorexia (83.8%), diarrhoea (2% to 35.6%), nausea (1% to 10%), vomiting (1% to 6.4%) and abdominal pain (2.2% to 5.8%) (36,37). On occasions, they might occur early in the disease course and precede other classical symptoms of COVID-19 (38). A cross-sectional study showed that 48.5% of patients with confirmed COVID-19 presented to hospital with only gastrointestinal symptoms as their presenting complaint (37) . The same study showed that 45% of patients with confirmed COVID-19 had both gastrointestinal and respiratory symptoms, whereas 3% had only gastrointestinal symptoms (37) . There is a case report described a patient who presented with only fever and diarrhoea without associated An interesting case report described a 42-year-old male patient who had an 8-day history of abdominal pain, back pain and testicular pain (42) . On abdominal examination, there was diffuse abdominal tenderness, and testicular exam was normal. Abdomen and pelvis CT captured the lung bases and showed basal GGO and consolidation, in addition to signs of colitis in sigmoid and distal descending colon. The patient was treated for pneumonia and colitis, and discharged home with instruction to follow-up with his primary care physician. After discharge the patient informed the primary care physician that he was tested positive for COVID-19. He was offered the test one day prior to his emergency department presentation due to history of recent travel 2 weeks before the presentation (42) .

Therefore, it is important to recognise patients with COVID-19 presenting to hospital with only gastrointestinal symptoms even with the absence of other symptoms. This kind of awareness improves early diagnosis and isolation of suspected patients which helps to reduce risk of transmission from patients to patients and patients to doctors.

The main reported ocular manifestation in patients with COVID-19 in the literature so far was conjunctivitis. It was reported in association with other symptoms of COVID-19, and on rare occasions, excessive eye watering (epiphora) was reported as the only initial presenting feature (43) . A case series study showed that almost one third of patients with confirmed COVID-19 infection had clinical signs of conjunctivitis (43) . It was reported in higher frequency in patients with more severe disease. 16.7% of COVID-19 patients with clinical features of conjunctivitis had positive RT-PCR results from both pharyngeal and conjunctival swabs (43) . In conclusion, ocular manifestations could be used as a clinical indicator of disease severity. In addition, giving the positive RT-PCR results from conjunctival swabs, transmission of COVID-19 infection by tears is a possibility to consider (44). This emphasises the importance of using eye protection by healthcare professionals in the frontlines.

Skin rash has been reported in 0.2% of patients with confirmed COVID-19 infection (13). It can occur at the onset of the illness or during hospital stay (45). The types of reported skin rash are; erythematous Accepted Article rash, widespread urticaria, chickenpox-like vesicles, localised pruritic lesions and petechial skin rash (45, 46, 47) . Skin rash commonly involves the trunk, However, there is a reported case of skin rash localised to heal and spare the trunk (45,46). Skin rash can be a delayed presentation in COVID-19. A case report described a patient presented with bilateral pruritic lesions in heals 13 days after the onset of typical symptoms of COVID-19 (46). Furthermore, skin rash has been reported as the initial manifestation of the disease. In a case report, a patient presented with diffuse erythematous urticarial rash 48 hours before he developed classical symptoms and diagnosed as COVID-19 (48). Another interesting case report described a patient who presented with petechial skin rash and thrombocytopenia (47) . This case was initially misdiagnosed as Dengue fever. The correct diagnosis of COVID-19 was eventually made when the patient developed respiratory symptoms later on in the disease course. Therefore, having the knowledge regarding the cutaneous manifestations of COVID-19 is important to avoid delayed or misdiagnosis as patients can present early with skin rash even without associated fever or respiratory symptoms.

There is a growing concern regarding whether COVID-19 could have a negative impact on male reproductive function. It is argued that SARS-CoV-2 could cause direct testicular damage through binding with testicular ACE2 receptors, which are highly expressed in the testis (49,50). It could also damage the testis indirectly by inducing testicular inflammatory and immune response (49,50). A study conducted on 81 male patients with COVID-19 showed low testosterone level, high luteinizing hormone (LH) level and low testosterone/LH ratio (51). This pattern indicates the possible viral testicular damage which subsequently affects the function of Leydig cells. In fact, it is not clear whether testicular damage induced by COVID-19 could lead to permanent fertility dysfunction. It has been reported that semen analysis following COVID-19 infection showed a low sperm concentration with low motility for up to three months post-infection (52) . This might indicate that the effect of COVID-19 on male fertility might be only transient. However, as the evidence is insufficient, a longterm follow-up of recovered male patients is required to investigate the long-term impact of COVID-19 on the male reproductive function.

Children with COVID-19 have been reported to present as asymptomatic or only with mild symptoms of respiratory or gastrointestinal system (53) . However, concerns have been raised regarding that a multisystem inflammatory syndrome similar to Kawasaki disease could be related to COVID-19 in children (54) . Reports have described children diagnosed with Kawasaki-like illness in the setting of confirmed COVID-19 infection (55, 56). A retrospective study from Italy showed a 30-fold increased incidence of Kawasaki-like disease cases in the Bergamo province following the COVID-19 epidemic, compared to the monthly incidence of the previous 5 years (57). Although the etiology of Kawasaki disease remains unknown, the possible association between Covid-19 and Kawasaki disease cannot be excluded (54) .

Recent studies have also shown that infants are more likely to present with atypical clinical symptoms, compared to older children (58) . A study reported five infants diagnosed with COVID-19, who presented with isolated fever and reduced oral intake, without associated respiratory symptoms (58) .

Although four of them developed neurological symptoms at admission such as drowsiness, hypotonia and moaning sounds, CSF samples tested negative for SARS-CoV-2.

Extrapulmonary and atypical presentations of COVID-19 can be the only symptoms during initial presentation to hospital. If they are under-recognised by the doctors, this might lead to misdiagnosis or delayed diagnosis. Therefore, the knowledge of these clinical presentations of COVID-19 is important as it assists in early diagnosis and early isolation of suspected patients, which helps to limit the 

COVID-19) -events as they happen

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Atypical symptoms in COVID-19: the many guises of a common culprit

Article: COVID-19 in Older Adults -Key Points for Emergency Department Providers

Atypical Clinical Presentation of Geriatric Syndrome in Elderly Patients With Pneumonia or Coronary Artery Disease

Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

The single cell RNA seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019 nCoV infection

Clinical Characteristics of Coronavirus Disease 2019 in China

Novel Coronavirus (COVID-19) Pneumonia with Haemoptysis as the Initial Symptom: CT and Clinical Features

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

COVID-19 pneumonia with haemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

ST-Segment Elevation in Patients with Covid-19 -A Case Series

Nervous system involvement after infection with COVID-19 and other coronaviruses

Guillain-Barré Syndrome Associated with SARS-CoV-2

Syndrome Associated with Zika Virus Infection in Colombia

Primary Cytomegalovirus Infection Causing Guillain-Barré Syndrome in a Living Renal Allograft Recipient. Case Reports in Transplantation

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence

Encephalitis as a clinical manifestation of COVID-19

Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Crosssectional Study

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Presentation of new onset anosmia during the COVID-19 pandemic

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Abdominal and testicular pain: An atypical presentation of COVID-19

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

COVID-19 can present with a rash and be mistaken for dengue

51-Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored

Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China

An Etiology or Coincidental Infection? The Pediatric Infectious Disease Journal

COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. The Lancet

Atypical presentation of COVID-19 in young infants. The Lancet